Management of Patients with Genital Endometriosis: New Strategies
https://doi.org/10.31550/1727-2378-2023-22-5-89-94
Abstract
Aim: To analyze modern approaches to the diagnosis and treatment of genital endometriosis.
Key points. Endometriosis is one of the most common gynecological diseases, affecting mainly women of reproductive age, the main manifestations of which are chronic pelvic pain and infertility. Constant pelvic pain, which reduces the quality of life, leads to the fact that patients are in a state of prolonged stress, and they have behavioral disorders. According to the latest world recommendations, drug treatment is the first line of therapy for endometriosis, if pregnancy is not a priority at this stage. There are many imaging methods for diagnosing this disease, but the search for non-invasive markers of endometriosis that can reliably confirm the diagnosis is still ongoing.
Conclusion. An interdisciplinary approach and the choice of adequate treatment for endometriosis at each stage of a woman's life can limit unnecessary surgery and better meet the needs of patients.
About the Authors
N. V. Ermolova
Rostov State Medical University
Russian Federation
Russian Federation
344022; 29 Nahichevansky Ave.; Rostov-on-Don
Yu. A. Petrov
Rostov State Medical University
Russian Federation
Russian Federation
344022; 29 Nahichevansky Ave.; Rostov-on-Don
M. A. Levkovich
Rostov State Medical University
Russian Federation
Russian Federation
344022; 29 Nahichevansky Ave.; Rostov-on-Don
A. V. Savchenko
City Emergency Hospital in Rostov-on-Don
Russian Federation
Russian Federation
344068; 88/35 Bodraya Str.; Rostov-on-Don
K. V. Slesareva
Rostov State Medical University
Russian Federation
Russian Federation
344022; 29 Nahichevansky Ave.; Rostov-on-Don
References
1. Zondervan K.T., Becker C.M., Missmer S.A. Endometriosis. N. Engl. J. Med. 2020;382(13):1244–56. DOI: 10.1056/NEJMra1810764
2. Hill C.J., Fakhreldin M., Maclean A., Dobson L. et al. Endometriosis and fallopian tubes: theories of origin and clinical implications. J. Clin. Med. 2020;9(6):1905. DOI: 10.3390/jcm9061905
3. Parazzini F., Esposito G., Tozzi L., Noli S. et al. Epidemiology of endometriosis and its comorbidities. Eur. J. Obstet. Gynecol. Reprod. Biol. 2017;209:3–7. DOI: 10.1016/j.ejogrb.2016.04.021
4. Gambadauro P., Carli V., Hadlaczky G. Depressive symptoms among women with endometriosis : a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2019;220(3):230–41. DOI: 10.1016/j.ajog.2018.11.123
5. As-Sanie S., Black R., Giudice L.C., Gray Valbrun T. et al. Assessing research gaps and unmet needs in endometriosis. Am. J. Obstet. Gynecol. 2019;221(2):86–94. DOI: 10.1016/j.ajog.2019.02.033
6. Škegro B., Bjedov S., Mikuš M., Mustač F. et al. Endometriosis, pain and mental health. Psychiatr. Danub. 2021;33(suppl.4):632–6.
7. Casalechi M., Vieira-Lopes M., Quessada M.P., Arão T.C. et al. Endometriosis and related pelvic pain: association with stress, anxiety and depressive symptoms. Minerva Obstet Gynecol. 2021;73(3):283–9. DOI: 10.23736/S2724-606X.21.04704-3
8. Walker A.K., Kavelaars A., Heijnen C.J., Dantzer R. Neuroinflammation and comorbidity of pain and depression. Pharmacol. Rev. 2013;66(1):80–101. DOI: 10.1124/pr.113.008144
9. Harsanyi S., Kupcova I., Danisovic L., Klein M. Selected biomarkers of depression: what are the effects of cytokines and inflammation? Int. J. Mol. Sci. 2022;24(1):578. DOI: 10.3390/ijms24010578
10. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009;71(2):171–86. DOI: 10.1097/PSY.0b013e3181907c1b
11. Nabi M.Y., Nauhria S., Reel M., Londono S. et al. Endometriosis and irritable bowel syndrome: a systematic review and meta-analyses. Front. Med. (Lausanne). 2022;9:914356. DOI: 10.3389/fmed.2022.914356
12. Schomacker M.L., Hansen K.E., Ramlau-Hansen C.H., Forman A. Is endometriosis associated with irritable bowel syndrome? A cross-sectional study. Eur. J. Obstet. Gynecol. Reprod. Biol. 2018;231:65–9. DOI: 10.1016/j.ejogrb.2018.10.023
13. Baker J.M., Al-Nakkash L., Herbst-Kralovetz M.M. Estrogen-gut microbiome axis: physiological and clinical implications. Maturitas. 2017;103:45–53. DOI: 10.1016/j.maturitas.2017.06.025
14. Rowlands I.J., Hockey R., Abbott J.A., Montgomery G.W. et al. Body mass index and the diagnosis of endometriosis: findings from a national data linkage cohort study. Obes. Res. Clin. Pract. 2022;16(3):235–41. DOI: 10.1016/j.orcp.2022.04.002
15. Vercellini P., Eskenazi B., Consonni D., Somigliana E. et al. Oral contraceptives and risk of endometriosis : a systematic review and meta-analysis. Hum. Reprod. Update. 2011;17(2):159–70. DOI: 10.1093/humupd/dmq042
16. Chapron C., Souza C., Borghese B., Lafay-Pillet M.C. et al. Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum. Reprod. 2011;26(8):2028–35. DOI: 10.1093/humrep/der156
17. Moura A.P.C., Ribeiro H.S.A.A., Bernardo W.M., Simões R. et al. Accuracy of transvaginal sonography versus magnetic resonance imaging in the diagnosis of rectosigmoid endometriosis : systematic review and meta-analysis [published correction appears in PLoS One. 2019;14(8):e0221499]. PLoS One. 2019;14(4):e0214842. DOI: 10.1371/journal.pone.0214842
18. Chowdary P., Stone K., Ma T., Readman E. et al. Multicentre retrospective study to assess diagnostic accuracy of ultrasound for superficial endometriosis — are we any closer? Aust. N. Z. J. Obstet. Gynaecol. 2019;59(2):279–84. DOI: 10.1111/ajo.12911
19. Guo C., Zhang C. Platelet-to-lymphocyte ratio and CA125 level as a combined biomarker for diagnosing endometriosis and predicting pelvic adhesion severity. Front. Oncol. 2022;12:896152. DOI: 10.3389/fonc.2022.896152
20. Xue Y.H., You L.T., Ting H.F., Chen Y.W. et al. Increased risk of rheumatoid arthritis among patients with endometriosis: a nationwide population-based cohort study. Rheumatology (Oxford). 2021;60(7):3326–33. DOI: 10.1093/rheumatology/keaa784
21. Kusunoki M., Fujiwara Y., Komohara Y., Imamura Y. et al. Hemoglobin-induced continuous activation of macrophages in endometriotic cysts: a potential mechanism of endometriosis development and carcinogenesis. Med. Mol. Morphol. 2021;54(2):122–32. DOI: 10.1007/s00795-020-00272-4
22. Chapron C., Marcellin L., Borghese B., Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat. Rev. Endocrinol. 2019;15(11):666–82. DOI: 10.1038/s41574-019-0245-z
23. Kitajima M., Khan K.N., Harada A., Taniguchi K. et al. Association between ovarian endometrioma and ovarian reserve. Front. Biosci. (Elite Ed). 2018;10(1):92–102. DOI: 10.2741/e810
24. Muzii L., Galati G., Di Tucci C., Di Feliciantonio M. et al. Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain. Gynecol. Endocrinol. 2020;36(1):81–3. DOI: 10.1080/09513590.2019.1640199
25. Králíčková M., Laganà A.S., Ghezzi F., Vetvicka V. Endometriosis and risk of ovarian cancer: what do we know? Arch. Gynecol. Obstet. 2020;301(1):1–10. DOI: 10.1007/s00404-019-05358-8
26. Pejovic T., Thisted S., White M., Nezhat F.R. Endometriosis and endometriosis-associated ovarian cancer (EAOC). Adv. Exp. Med. Biol. 2020;1242:73–87. DOI: 10.1007/978-3-030-38474-6_5
27. Khan K.N., Fujishita A., Koshiba A., Kuroboshi H. et al. Biological differences between intrinsic and extrinsic adenomyosis with coexisting deep infiltrating endometriosis. Reprod. Biomed. Online. 2019;39(2):343–53. DOI: 10.1016/j.rbmo.2019.03.210
28. Chapron C., Vannuccini S., Santulli P., Abrão M.S. et al. Diagnosing adenomyosis: an integrated clinical and imaging approach. Hum. Reprod. Update. 2020;26(3):392–411. DOI: 10.1093/humupd/dmz049
29. Tellum T., Nygaard S., Lieng M. Noninvasive diagnosis of adenomyosis : a structured review and meta-analysis of diagnostic accuracy in imaging. J. Minim. Invasive Gynecol. 2020;27(2):408–18.e3. DOI: 10.1016/j.jmig.2019.11.001
30. Saraswat L., Ayansina D., Cooper K.G., Bhattacharya S. et al. Impact of endometriosis on risk of further gynaecological surgery and cancer: a national cohort study. BJOG. 2018;125(1):64–72. DOI: 10.1111/1471-0528.14793
31. Edi R., Cheng T. Endometriosis: evaluation and treatment. Am. Fam. Physician. 2022;106(4):397–404.
32. Vercellini P., Buggio L., Frattaruolo M.P., Borghi A. et al. Medical treatment of endometriosis-related pain. Best Pract. Res. Clin. Obstet. Gynaecol. 2018;51:68–91. DOI: 10.1016/j.bpobgyn.2018.01.015
33. Piacenti I., Viscardi M.F., Masciullo L., Sangiuliano C. et al. Dienogest versus continuous oral levonorgestrel/EE in patients with endometriosis: what's the best choice? Gynecol. Endocrinol. 2021;37(5):471–5. DOI: 10.1080/09513590.2021.1892632
34. Casper R.F. Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil. Steril. 2017;107(3):533–6. DOI: 10.1016/j.fertnstert.2017.01.003
35. Murji A., Biberoğlu K., Leng J., Mueller M.D. et al. Use of dienogest in endometriosis : a narrative literature review and expert commentary. Curr. Med. Res. Opin. 2020;36(5):895–907. DOI: 10.1080/03007995.2020.1744120
36. Hughes G.C., Choubey D. Modulation of autoimmune rheumatic diseases by oestrogen and progesterone. Nat. Rev. Rheumatol. 2014;10(12):740–51. DOI: 10.1038/nrrheum.2014.144
37. Collins M.K., McCutcheon C.R., Petroff M.G. Impact of estrogen and progesterone on immune cells and host-pathogen interactions in the lower female reproductive tract. J. Immunol. 2022;209(8):1437–49. DOI: 10.4049/jimmunol.2200454
38. Moulton V.R. Sex hormones in acquired immunity and autoimmune disease. Front. Immunol. 2018;9:2279. DOI: 10.3389/fimmu.2018.02279
39. Liu Y., Wang J., Zhang X. An update on the multifaceted role of NF-kappa B in endometriosis. Int. J. Biol. Sci. 2022;18(11):4400–13. DOI: 10.7150/ijbs.72707
40. Mita S., Shimizu Y., Notsu T., Imada K. et al. Dienogest inhibits Toll-like receptor 4 expression induced by costimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells. Fertil. Steril. 2011;96(6):1485–9.e4. DOI: 10.1016/j.fertnstert.2011.09.040
41. Arosh J.A., Sivakumar K.K., Lee J., Banu S.K. Effects of selective inhibition of prostaglandin E2 receptors EP2 and EP4 on the miRNA profile in endometriosis. Mol. Cell Endocrinol. 2022;558:111728. DOI: 10.1016/j.mce.2022.111728
42. Koshiba A., Mori T., Okimura H., Akiyama K. et al. Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries. J. Obstet. Gynaecol. Res. 2018;44(10):1970–6. DOI: 10.1111/jog.13725
43. Lee J.H., Song J.Y., Yi K.W., Lee S.R. et al. Effectiveness of dienogest for treatment of recurrent endometriosis: multicenter data. Reprod. Sci. 2018;25(10):1515–22. DOI: 10.1177/1933719118779733
44. Vignali M., Belloni G.M., Pietropaolo G., Barbasetti Di Prun A. et al. Effect of dienogest therapy on the size of the endometrioma. Gynecol. Endocrinol. 2020;36(8):723–7. DOI: 10.1080/09513590.2020.1725965
45. Del Pup L., Berretta M. As dienogest effectively suppress could it also reduce endometriosis associated ovarian cancers? A further motivation for long-term medical treatment. World Cancer Res. J. 2015;2(2):e526.
46. Vannuccini S., Luisi S., Tosti C., Sorbi F. et al. Role of medical therapy in the management of uterine adenomyosis. Fertil. Steril. 2018;109(3):398–405. DOI: 10.1016/j.fertnstert.2018.01.013
47. Ota I., Taniguchi F., Ota Y., Nagata H. et al. A controlled clinical trial comparing potentprogestins, LNG-IUS and dienogest, for the treatment of women with adenomyosis. Reprod. Med. Biol. 2021;20(4):427–34. DOI: 10.1002/rmb2.12408
48. Yang S., Liu Y., Wen J., Sun Y. et al. Clinical efficacy of dienogest versus levonorgestrel-releasing intrauterine system for adenomyosis. Evid. Based Complement Alternat. Med. 2022;2022:1995472. DOI: 10.1155/2022/1995472
49. Green I.C., Burnett T., Famuyide A. Persistent pelvic pain in patients with endometriosis. Clin. Obstet. Gynecol. 2022;65(4):775–85. DOI: 10.1097/GRF.0000000000000712
Review
For citations:
Ermolova N.V., Petrov Yu.A., Levkovich M.A., Savchenko A.V., Slesareva K.V. Management of Patients with Genital Endometriosis: New Strategies. Title. 2023;22(5):89-94. (In Russ.) https://doi.org/10.31550/1727-2378-2023-22-5-89-94
Views:
32
Email this article 